These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17984676)

  • 1. It's About Blood Pressure Reduction and Control.
    MacLaughlin EJ; Saseen JJ
    Am J Hypertens; 2024 May; 37(6):396-398. PubMed ID: 38447001
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
    Minami J; Ohno E; Furukata S; Ishimitsu T; Matsuoka H
    J Hum Hypertens; 2009 Oct; 23(10):683-6. PubMed ID: 19369955
    [No Abstract]   [Full Text] [Related]  

  • 3. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationships between initial blood pressure and the response to different antihypertensive agents.
    Meredith PA; Murray LS; McInnes GT
    J Hypertens; 2007 Dec; 25(12):2513-4; author reply 2514. PubMed ID: 17984676
    [No Abstract]   [Full Text] [Related]  

  • 5. [HOSP study].
    Kawano Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():465-9. PubMed ID: 16983778
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM; Hilkert R
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.
    Fabia MJ; Abdilla N; Oltra R; Fernandez C; Redon J
    J Hypertens; 2007 Jul; 25(7):1327-36. PubMed ID: 17563549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory or home blood pressure monitoring for treatment adjustment?
    Stergiou GS
    Am J Hypertens; 2006 May; 19(5):475-6. PubMed ID: 16647617
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.